2seventy bio Inc (TSVT)
4.59
+0.34
(+7.87%)
USD |
NASDAQ |
Apr 29, 16:00
4.60
+0.01
(+0.22%)
Pre-Market: 20:00
2seventy bio Profit Margin (Quarterly): -531.8% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -531.8% |
| September 30, 2023 | -595.3% |
| June 30, 2023 | -116.8% |
| March 31, 2023 | -113.0% |
| December 31, 2022 | -41.20% |
| September 30, 2022 | -506.3% |
| June 30, 2022 | -574.2% |
| Date | Value |
|---|---|
| March 31, 2022 | -1.02K% |
| December 31, 2021 | -380.3% |
| September 30, 2021 | -311.6% |
| June 30, 2021 | -1.15K% |
| March 31, 2021 | -732.7% |
| December 31, 2020 | -775.4% |
| September 30, 2020 | -391.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.15K%
Minimum
Jun 2021
-41.20%
Maximum
Dec 2022
-516.7%
Average
-519.0%
Median
Profit Margin (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | -100.4% |
| Johnson & Johnson | 25.04% |
| Regeneron Pharmaceuticals Inc | 33.77% |
| Macrogenics Inc | -502.7% |
| Akebia Therapeutics Inc | 1.09% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -66.29% |
| Return on Assets | -32.86% |
| Return on Invested Capital | -66.29% |
| Gross Profit Margin (Quarterly) | 70.54% |
| Operating Margin (Quarterly) | -560.5% |
| Return on Net Operating Assets | -64.00% |